Riverview Capital Advisers
IMNN icon

Riverview Capital Advisers’s Imunon IMNN Stock Holding History

Riverview Capital Advisers’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-34,364
Closed -$248K – 90
2026
Q2 		$248K Hold
34,364
– – 0.07% 79
2026
Q1 		$248K Hold
34,364
– – 0.08% 74
2025
Q4 		$248K Hold
34,364
– – 0.08% 80
2025
Q3 		$248K Buy
34,364
+33,466
+3,727% +$224K 0.07% 85
2025
Q2 		$9.37K Buy
+898
New +$12.3K ﹤0.01% 95

Other funds holding IMNN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nvest Financial
Nvest Financial Portsmouth, New Hampshire $329M AUM 20.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Game Plan Financial Advisors
Game Plan Financial Advisors Westlake, Ohio $264M AUM 21.06% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Riverview Capital Advisers's IMNN Position: Q3 2026 in Review

Riverview Capital Advisers sold out of Imunon (IMNN) in Q3 2026, closing a stake of 34,364 shares — an estimated $248K sold.

Riverview Capital Advisers first reported a position in IMNN in Q2 2025 and held it in 5 quarters. The position peaked at $248K in Q2 2026. 11 funds tracked by Wall St. Rank hold IMNN as of Q3 2026.

  • Riverview Capital Advisers reported no remaining Imunon position as of Q3 2026 after selling out during the quarter.
  • Riverview Capital Advisers sold 34,364 Imunon shares in Q3 2026, an estimated $248K.
  • Riverview Capital Advisers first reported a position in Imunon in Q2 2025 and held it in 5 quarters.
  • Riverview Capital Advisers's Imunon position peaked at $248K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Imunon as of Q3 2026.

Based on Riverview Capital Advisers's 13F filing for Q3 2026, filed 12 Nov 2026.